Ketone body metabolism in diabetic and non-diabetic heart failure

Ningjing Qian1, Yaping Wang2

  • 1The Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China.

Heart Failure Reviews
|October 16, 2019
PubMed

Insights

Heart failure (HF) involves metabolic imbalances. Ketone bodies offer an alternative energy source, potentially improving heart function, especially in diabetic patients with heart failure.

Area of Science:

  • Cardiology
  • Metabolic Diseases
  • Biochemistry

Background:

  • Heart failure (HF) is a prevalent cardiovascular disease with significant global impact.
  • Metabolic dysfunction and altered substrate utilization are key factors in HF development.
  • Diabetes mellitus exacerbates HF, leading to distinct metabolic patterns and outcomes.

Purpose of the Study:

  • To review alterations in ketone body metabolism during heart failure.
  • To compare metabolic patterns in diabetic versus non-diabetic HF.
  • To explore the potential mechanisms of ketone body utilization in HF.

Main Methods:

  • Literature review of studies on ketone body metabolism in HF.
  • Analysis of data from human patients and animal models.
  • Comparison of substrate utilization in diabetic and non-diabetic HF cohorts.

Main Results:

  • Ketone bodies serve as an alternative myocardial energy source in HF.
  • Diabetic HF exhibits unique metabolic characteristics compared to non-diabetic HF.
  • Ketone body metabolism is altered in HF, with potential therapeutic implications.

Conclusions:

  • Ketone body metabolism is significantly altered in heart failure.
  • Understanding these alterations may reveal therapeutic strategies for HF, particularly in diabetic patients.
  • Ketone bodies represent a promising alternative fuel for the failing heart.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
760
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
721
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
651
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
188